LabCorp's Orchid Buy, a Wise Move, Will Provide UK Foothold, Fatten Paternal, Forensic Plays

Though this kind of acquisition was unexpected — LabCorp has been saying for years how it wants to expand its esoteric-testing play — the bid turns out to be a wise move.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.